Status:
COMPLETED
Efficacy Parecoxib and Ketorolac as Preemptive Analgesia in Spine Fusion
Lead Sponsor:
Prince of Songkla University
Conditions:
Postoperative Pain
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the efficacy of Parecoxib and Ketorolac as a preemptive analgesia in patients undergoing lumbar spinal fusion.
Detailed Description
A prospective, double-blinded randomized control trial. Randomly allocated patient undergoing posterior lumbar spinal fusion into 3 groups (n=32) to receive Parecoxib, Ketorolac and Placebo around 30 ...
Eligibility Criteria
Inclusion
- Patients undergoing lumbar spinal fusion for one to three levels
- ASA class I or II
Exclusion
- History of allergy to Sulfa group
- History of allergy to OPOID or NSAIDs
- Contraindicate to NSAIDs use
- History of coagulopathy or platelet disfunction
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT01859585
Start Date
March 1 2011
End Date
March 1 2013
Last Update
May 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Prince of Songkla University
Hadyai, Sonkla, Thailand, 90110